Literature DB >> 11853659

Update on Lymphatic Filarial Infections.

Paul B. Keiser1, Thomas B. Nutman.   

Abstract

Filarial infections remain significant causes of disability in tropical areas worldwide. However, insights into the developmental and molecular biology of the parasite and the immunobiology of the host response to infection have advanced our understanding, even as progress is being made towards implementing eradication programs. This article summarizes some of the recent advances in the understanding of filarial biology and parasite immune evasion mechanisms, and reviews those newer aspects of diagnosis and treatment most relevant to clinicians.

Entities:  

Year:  2002        PMID: 11853659     DOI: 10.1007/s11908-002-0069-0

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  47 in total

1.  Genital manifestations and reproductive health in female residents of a Wuchereria bancrofti-endemic area in Tanzania.

Authors:  P Bernhard; R W Makunde; P Magnussen; M M Lemnge
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Jul-Aug       Impact factor: 2.184

Review 2.  Linking proteome and genome: how to identify parasite proteins.

Authors:  P D Ashton; R S Curwen; R A Wilson
Journal:  Trends Parasitol       Date:  2001-04

3.  Annual single-dose diethylcarbamazine plus ivermectin for control of bancroftian filariasis: comparative efficacy with and without vector control.

Authors:  R Reuben; R Rajendran; I P Sunish; T R Mani; S C Tewari; J Hiriyan; A Gajanana
Journal:  Ann Trop Med Parasitol       Date:  2001-06

4.  Transmission intensity and the immunoepidemiology of bancroftian filariasis in East Africa.

Authors:  E Michael; P E Simonsen; M Malecela; W G Jaoko; E M Pedersen; D Mukoko; R T Rwegoshora; D W Meyrowitsch
Journal:  Parasite Immunol       Date:  2001-07       Impact factor: 2.280

5.  Inhibitors of the lipoxygenase pathway block development of Brugia malayi L3 in vitro.

Authors:  H L Smith; T V Rajan
Journal:  J Parasitol       Date:  2001-04       Impact factor: 1.276

6.  The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis.

Authors:  W F Gregory; A K Atmadja; J E Allen; R M Maizels
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

7.  The filarial genome project: analysis of the nuclear, mitochondrial and endosymbiont genomes of Brugia malayi.

Authors:  S A Williams; M R Lizotte-Waniewski; J Foster; D Guiliano; J Daub; A L Scott; B Slatko; M L Blaxter
Journal:  Int J Parasitol       Date:  2000-04-10       Impact factor: 3.981

Review 8.  Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective.

Authors:  G Dreyer; J Norões; J Figueredo-Silva; W F Piessens
Journal:  Parasitol Today       Date:  2000-12

Review 9.  Lymphatic filariasis: new insights and prospects for control.

Authors:  T B Nutman
Journal:  Curr Opin Infect Dis       Date:  2001-10       Impact factor: 4.915

10.  The ICT Filariasis Test: A rapid-format antigen test for diagnosis of bancroftian filariasis.

Authors:  G J Weil; P J Lammie; N Weiss
Journal:  Parasitol Today       Date:  1997-10
View more
  3 in total

1.  Cytochemical characterization of the third-stage larva of Wuchereria bancrofti (Nematoda: Filarioidea).

Authors:  L F Silva; L C Alves; S S Santos; M G S Cavalcanti; C A Peixoto
Journal:  Parasitol Res       Date:  2006-02-01       Impact factor: 2.289

2.  Molecular characterization of a Brugia malayi transglutaminase.

Authors:  Eswaran Devarajan; Pankaj Kumar Mishra; Shiva Thirugnanam; Kapil Mehta; Ramaswamy Chandrashekar; Kaliraj Perumal
Journal:  Parasitol Res       Date:  2004-05-01       Impact factor: 2.289

3.  Filarial infection during pregnancy has profound consequences on immune response and disease outcome in children: A birth cohort study.

Authors:  Madhusmita Bal; Manoranjan Ranjit; Ashok K Satapathy; Hemant K Khuntia; Sanghamitra Pati
Journal:  PLoS Negl Trop Dis       Date:  2018-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.